Siga Technologies (SIGA) Non-Current Deferred Tax Liability (2010 - 2017)
Siga Technologies' (SIGA) quarterly Non-Current Deferred Tax Liability came in at $306449.0 in Q3 2017, up 8.71% YoY from $281889.0 in Q3 2016, and little changed on a QoQ basis from $307256.0 in Q2 2017.
Siga Technologies (SIGA) Non-Current Deferred Tax Liability (2010 - 2017) Analysis & Trends
Siga Technologies (SIGA) has 5 years of Non-Current Deferred Tax Liability data on file, last reported at $306449.0 in Q3 2017.
- Quarterly Non-Current Deferred Tax Liability rose 8.71% year-over-year to $306449.0 in Q3 2017, while the trailing twelve-month figure through Sep 2017 was $306449.0 (up 8.71% YoY) and the FY2016 annual result came in at $286066.0, up 7.69% from the prior year.
- Non-Current Deferred Tax Liability steadied at $306449.0 in Q3 2017, from $307256.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $7.5 million in Q3 2015 to a low of $240973.0 in Q3 2014.
- A 4-year average of $1.8 million and a median of $286066.0 in 2016 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2015 — Non-Current Deferred Tax Liability surged 3020.62% — and 2016, when it tumbled 96.25%.
- Tracing SIGA's Non-Current Deferred Tax Liability over 4 years: stood at $244540.0 in 2014, then advanced by 8.63% to $265643.0 in 2015, then rose by 7.69% to $286066.0 in 2016, then increased by 7.13% to $306449.0 in 2017.
- The last three Non-Current Deferred Tax Liability figures came in at $306449.0 (Q3 2017), $307256.0 (Q2 2017), and $307256.0 (Q1 2017), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Siga Technologies | 213.02 Mn | 58.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 306,449.00 |
| Sep 30, 2017 | 306,449.00 |
| Jun 30, 2017 | 307,256.00 |
| Jun 30, 2017 | 307,256.00 |
| Mar 31, 2017 | 307,256.00 |
| Mar 31, 2017 | 307,256.00 |
| Dec 31, 2016 | 286,066.00 |
| Dec 31, 2016 | 286,066.00 |
| Sep 30, 2016 | 281,889.00 |
| Sep 30, 2016 | 281,889.00 |
| Jun 30, 2016 | 277,088.00 |
| Jun 30, 2016 | 277,088.00 |
| Mar 31, 2016 | 277,895.00 |
| Mar 31, 2016 | 277,895.00 |
| Dec 31, 2015 | 265,643.00 |
| Dec 31, 2015 | 265,643.00 |
| Sep 30, 2015 | 7.52 Mn |
| Sep 30, 2015 | 7.52 Mn |
| Jun 30, 2015 | 7.07 Mn |
| Jun 30, 2015 | 7.07 Mn |